Back to Search
Start Over
Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis
- Source :
- Alimentary Pharmacology & Therapeutics. 11:335-340
- Publication Year :
- 1997
- Publisher :
- Wiley, 1997.
-
Abstract
- Background: Topical treatments with steroids or mesalazine are the most effective treatments for idiopathic proctitis. Aim: to compare the efficacy and tolerance of mesalazine suppositories vs. hydrocortisone acetate foam in the treatment of acute proctitis. Patients and methods: 242 patients with active idiopathic proctitis were randomized to receive once daily either one Pentasa suppository (mesalazine 1 g) or 100 mg hydrocortisone (Colofoam) for 14–21 days (until remission). Disease activity and tolerance of the treatments were assessed using a daily questionnaire, by physician assessment, and endoscopy score. Results: Both treatments induced a significant reduction in disease activity. Mesalazine suppositories were significantly more effective than hydrocortisone on rectal blood loss (P=0.002) and mucus (P=0.02) parameters, and on the degree of the decrease in endoscopy score (P=0.02). No significant difference was observed between treatments concerning histology or tolerance. Conclusion: Mesalazine suppositories were as well-tolerated as hydrocortisone foam, but were more effective for some parameters of disease activity.
- Subjects :
- Adult
Male
medicine.medical_specialty
Hydrocortisone
Administration, Topical
medicine.medical_treatment
Anti-Inflammatory Agents
Suppository
Proctoscopy
Gastroenterology
chemistry.chemical_compound
Mesalazine
Internal medicine
Humans
Medicine
Proctitis
Pharmacology (medical)
Mesalamine
Chemotherapy
Hepatology
medicine.diagnostic_test
business.industry
Suppositories
Anti-Inflammatory Agents, Non-Steroidal
Geriatric assessment
medicine.disease
Endoscopy
Surgery
Aminosalicylic Acids
chemistry
Acute Disease
Toxicity
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 02692813
- Volume :
- 11
- Database :
- OpenAIRE
- Journal :
- Alimentary Pharmacology & Therapeutics
- Accession number :
- edsair.doi.dedup.....c4a811ef373d10791f320c9ac2cff1eb
- Full Text :
- https://doi.org/10.1046/j.1365-2036.1997.126297000.x